FDA Recalls Fentanyl-Bupivacaine Injection Due to Sterility Assurance Concerns
SCA Pharmaceuticals is recalling 130 cassettes of a fentanyl-bupivacaine epidural injection distributed nationwide due to lack of assurance of sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II drug recall with no reported illnesses or injuries. The hazard (lack of sterility assurance) represents a theoretical risk-of-harm to patients without confirmed contamination.
Plain-English summary
SCA Pharmaceuticals, LLC is recalling fentaNYL 500 mcg/100 mL combined with Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (CADD Cassette, NDC 70004-0251-64). The recall affects 130 cassettes distributed nationwide due to lack of assurance of sterility.
The two affected lots are: Lot #1223048722 (Exp 11/29/23) and Lot #1223049096 (Exp 12/15/23). This product is intended for epidural use only.
Patients currently using this product should contact their healthcare provider. Healthcare providers should quarantine affected cassettes and refer to the FDA recall notice for further instructions.
The recalled product
- Product
- fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0251-64, Bar Code 70004025164
- Manufacturer
- SCA Pharmaceuticals, LLC
- Category
- Drug — Injectable / Epidural
- Hazard
- sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1223048722
- Exp 11/29/23
- 1223049096
- Exp 12/15/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27